Neogen Corporation
NEOG Healthcare Medical Devices
Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025. In the quarter to August 2026, revenue grew 6.51%, EPS fell 132.1%, free cash flow grew 135.8% and total debt fell 2.31%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow NEOG
Neogen Corporation (NEOG) P/E ratio
Neogen Corporation has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 2,499× (March 2024) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 0.0× | — |
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 58.8× | (25.89%) |
| FY2021 | 79.3× | 24.80% |
| FY2020 | 63.6× | 29.72% |
| FY2019 | 49.0× | (21.52%) |
| FY2018 | 62.4× | 12.47% |
| FY2017 | 55.5× | 9.06% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Aug 2026 | 0.0× | — |
| May 2026 | 0.0× | — |
| Feb 2026 | 0.0× | — |
| Nov 2025 | 0.0× | — |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BFLY Butterfly Network, Inc. compare | n/m |
| ESTA Establishment Labs Holdings Inc. compare | n/m |
| NEOG Neogen Corporation | n/m |
| IRTC iRhythm Holdings, Inc. compare | n/m |
| AXGN AxoGen, Inc. compare | n/m |
| ATEC Alphatec Holdings, Inc. compare | n/m |
| INSP Inspire Medical Systems, Inc. compare | 14.8× |
| TMDX TransMedics Group, Inc. compare | 16.0× |
| UFPT UFP Technologies, Inc. compare | 31.2× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)